TrialClinical pharmacology in drug development2020

Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study.

Marie T Borin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.